231 related articles for article (PubMed ID: 18373022)
1. [Brazilian Consensus on second-generation antipsychotics and metabolic disorders].
Elkis H; Gama C; Suplicy H; Tambascia M; Bressan R; Lyra R; Cavalcante S; Minicucci W
Braz J Psychiatry; 2008 Mar; 30(1):77-85. PubMed ID: 18373022
[TBL] [Abstract][Full Text] [Related]
2. Metabolic monitoring for patients treated with antipsychotic medications.
Cohn TA; Sernyak MJ
Can J Psychiatry; 2006 Jul; 51(8):492-501. PubMed ID: 16933586
[TBL] [Abstract][Full Text] [Related]
3. Management of schizophrenia with obesity, metabolic, and endocrinological disorders.
Monteleone P; Martiadis V; Maj M
Psychiatr Clin North Am; 2009 Dec; 32(4):775-94. PubMed ID: 19944883
[TBL] [Abstract][Full Text] [Related]
4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
5. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
Rzewuska M
Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
[TBL] [Abstract][Full Text] [Related]
6. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
7. The metabolic effects of antipsychotic medications.
Newcomer JW; Haupt DW
Can J Psychiatry; 2006 Jul; 51(8):480-91. PubMed ID: 16933585
[TBL] [Abstract][Full Text] [Related]
8. [Schizophrenia and antipsychotics associated with the metabolic syndrome. An overview].
Scheepers-Hoeks AM; Wessels-Basten SJ; Scherders MJ; Bravenboer B; Loonen AJ; Kleppe RT; Grouls RJ
Tijdschr Psychiatr; 2008; 50(10):645-54. PubMed ID: 18951343
[TBL] [Abstract][Full Text] [Related]
9. [Schizophrenia, diabetes mellitus and antipsychotics].
Gury C
Encephale; 2004; 30(4):382-91. PubMed ID: 15538314
[TBL] [Abstract][Full Text] [Related]
10. Managing weight gain and metabolic issues in patients treated with atypical antipsychotics.
Henderson DC
J Clin Psychiatry; 2008 Feb; 69(2):e04. PubMed ID: 18363448
[TBL] [Abstract][Full Text] [Related]
11. Quality of monitoring for metabolic effects associated with second generation antipsychotics in patients with schizophrenia on public insurance.
Moeller KE; Rigler SK; Mayorga A; Nazir N; Shireman TI
Schizophr Res; 2011 Mar; 126(1-3):117-23. PubMed ID: 21168994
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic-Induced Metabolic Syndrome: A Review.
Akinola PS; Tardif I; Leclerc J
Metab Syndr Relat Disord; 2023 Aug; 21(6):294-305. PubMed ID: 37347965
[TBL] [Abstract][Full Text] [Related]
13. Weight gain, dyslipidemia and altered parameters for metabolic syndrome on first episode psychotic patients after six-month follow-up.
Attux C; Quintana MI; Chaves AC
Braz J Psychiatry; 2007 Dec; 29(4):346-9. PubMed ID: 17992359
[TBL] [Abstract][Full Text] [Related]
14. Schizophrenia, antipsychotics and metabolic disease.
Reynolds GP
J Psychopharmacol; 2007 Jun; 21(4):355-6. PubMed ID: 17656424
[No Abstract] [Full Text] [Related]
15. Second-generation antipsychotics and the metabolic syndrome.
Masand PS; Mago R
Curr Psychiatry Rep; 2005 Jun; 7(3):153-4. PubMed ID: 15935125
[No Abstract] [Full Text] [Related]
16. Metabolic and endocrine disturbances in psychiatric disorders: a multidisciplinary approach to appropriate atypical antipsychotic utilization.
Masand PS; Culpepper L; Henderson D; Lee S; Littrell K; Newcomer JW; Rasgon N
CNS Spectr; 2005 Oct; 10(10):suppl14 1-15. PubMed ID: 16404802
[TBL] [Abstract][Full Text] [Related]
17. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome in schizophrenia: a comparative study of antipsychotic-free/naïve and antipsychotic-treated patients from India.
Pallava A; Chadda RK; Sood M; Lakshmy R
Nord J Psychiatry; 2012 Jun; 66(3):215-21. PubMed ID: 22017264
[TBL] [Abstract][Full Text] [Related]
19. [Time for every psychiatric clinic to take full responsibility for metabolic side effects of antipsychotic drugs!].
Gothefors D; Jarbin H
Lakartidningen; 2010 Mar 24-30; 107(12):845-6. PubMed ID: 20432835
[No Abstract] [Full Text] [Related]
20. Antipsychotic-induced metabolic and cardiovascular side effects in schizophrenia: a novel mechanistic hypothesis.
Scigliano G; Ronchetti G
CNS Drugs; 2013 Apr; 27(4):249-57. PubMed ID: 23533011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
